Damyanovich AZ, Avery L, Staples JR, Marshall KW
(1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction
Pathologies of the haemolymphopoietic system Thrombocytopenia, leukopenia, anemia, agranulocytosis Immune system disorders Hypersensitivity reactions (urticaria, laryngeal edema, angioedema, anaphylactic shock) Nervous system disorders Dizziness Gastrointestinal disorders Gastrointestinal reaction Hepatobiliary pathologies Abnormal liver function, hepatitis Skin and subcutaneous tissue disorders Erythema multiforme, Stevens Johnson syndrome, Epidermal necrolysis, Skin rash Kidney and urinary disorders Acute renal failure, interstitial nephritis, hematuria, anuria
Clinical evidence shows injectable GLP-1 medications produce weight loss of 15-22% body weight reduction over 68 weeks in most patients
Myth: I will have acid reflux forever if I stay on this medication